logo

DRUG

Bright Minds·NASDAQ
--
--(--)
--
--(--)

DRUG fundamentals

During FY 2025, Bright Minds (DRUG) reported revenue of --, a YoY change of 0.00%. Net income was -8.78M, a YoY change of -323.42%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
FY,2019
H1,2020
FY,2020
H1,2021
9M,2021
FY,2021
Q1,2022
H1,2022
9M,2022
FY,2022
Q1,2023
H1,2023
9M,2023
FY,2023
Q1,2024
H1,2024
9M,2024
FY,2024
Q1,2025
H1,2025
FY,2025
TTM
Start Date
Oct 1, 2018
Oct 1, 2019
Oct 1, 2019
Oct 1, 2020
Oct 1, 2020
Oct 1, 2020
Oct 1, 2021
Oct 1, 2021
Oct 1, 2021
Oct 1, 2021
Oct 1, 2022
Oct 1, 2022
Oct 1, 2022
Oct 1, 2022
Oct 1, 2023
Oct 1, 2023
Oct 1, 2023
Oct 1, 2023
Oct 1, 2024
Oct 1, 2024
Oct 1, 2024
--
End Date
Sep 30, 2019
Mar 31, 2020
Sep 30, 2020
Mar 31, 2021
Jun 30, 2021
Sep 30, 2021
Dec 31, 2021
Mar 31, 2022
Jun 30, 2022
Sep 30, 2022
Dec 31, 2022
Mar 31, 2023
Jun 30, 2023
Sep 30, 2023
Dec 31, 2023
Mar 31, 2024
Jun 30, 2024
Sep 30, 2024
Dec 31, 2024
Mar 31, 2025
Sep 30, 2025
--
Fiscal Year-End
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
Sep 30
--
Operating Expenses
59.44K
--
34.08K
--
360.56K
+506.59%
1.79M
+5152.01%
4.66M
--
6.95M
+1826.92%
3.80M
--
7.49M
+318.26%
9.33M
+100.01%
10.89M
+56.75%
1.73M
-54.61%
3.24M
-56.69%
4.38M
-53.00%
5.46M
-49.89%
1.29M
-25.43%
1.67M
-48.60%
1.48M
-66.13%
2.09M
-61.72%
1.13M
-12.33%
3.46M
+107.63%
10.01M
+379.01%
10.01M
--
Selling, General and Administrative Expenses
0
--
177.02
--
7.70K
--
226.07K
+127610.71%
653.79K
--
935.76K
+12057.11%
338.06K
--
546.99K
+141.95%
663.24K
+1.44%
821.37K
-12.22%
76.68K
-77.32%
183.66K
-66.42%
963.06K
+45.21%
1.63M
+97.87%
165.93K
+116.41%
296.50K
+61.44%
439.13K
-54.40%
1.07M
-34.17%
175.72K
+5.90%
491.77K
+65.86%
1.84M
+72.17%
1.84M
--
Selling and Marketing Expenses
0
--
--
--
7.22K
--
--
--
--
--
672.41K
+9214.40%
--
--
--
--
--
--
401.30K
-40.32%
--
--
--
--
62.59K
--
88.23K
-78.01%
27.72K
--
27.03K
--
26.75K
-57.27%
30.79K
-65.10%
54.31K
+95.89%
114.43K
+323.33%
308.51K
+901.98%
308.51K
--
General and Administrative Expenses
0
--
--
--
478.12
--
--
--
--
--
155.55K
+32433.09%
--
--
--
--
--
--
347.77K
+123.58%
--
--
--
--
245.41K
--
205.99K
-40.77%
52.44K
--
92.47K
--
157.54K
-35.80%
195.40K
-5.14%
53.87K
+2.71%
246.35K
+166.42%
562.99K
+188.12%
562.99K
--
Research and Development Expenses
31.72K
--
33.91K
--
266.35K
+739.63%
1.11M
+3179.15%
3.31M
--
4.98M
+1770.59%
3.01M
--
6.08M
+446.78%
7.49M
+126.26%
8.86M
+77.78%
1.08M
-64.16%
2.11M
-65.24%
2.95M
-60.56%
3.69M
-58.29%
928.29K
-13.94%
982.79K
-53.49%
558.28K
-81.10%
873.37K
-76.36%
725.95K
-21.80%
2.51M
+155.35%
7.96M
+811.30%
7.96M
--
Loss on Impairment of Other Assets
--
--
--
--
0
--
--
--
--
--
0
--
--
--
--
--
--
--
1.45K
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Other Operating Expenses
27.72K
--
0
--
86.52K
+212.13%
452.16K
--
698.94K
--
1.03M
+1090.18%
454.68K
--
860.78K
+90.37%
1.17M
+67.91%
1.21M
+17.55%
570.49K
+25.47%
946.09K
+9.91%
466.69K
-60.23%
137.90K
-88.61%
192.70K
-66.22%
387.67K
-59.02%
487.14K
+4.38%
145.94K
+5.83%
226.56K
+17.57%
459.82K
+18.61%
206.54K
+41.52%
206.54K
--
Operating Income
-59.44K
--
-34.08K
--
-360.56K
-506.59%
-1.79M
-5152.01%
-4.66M
--
-6.95M
-1826.92%
-3.80M
--
-7.49M
-318.26%
-9.33M
-100.01%
-10.89M
-56.75%
-1.73M
+54.61%
-3.24M
+56.69%
-4.38M
+53.00%
-5.46M
+49.89%
-1.29M
+25.43%
-1.67M
+48.60%
-1.48M
+66.13%
-2.09M
+61.72%
-1.13M
+12.33%
-3.46M
-107.63%
-10.01M
-379.01%
-10.01M
--
Non-Operating Income (Loss)
0
--
--
--
0
--
--
--
--
--
121.60K
--
--
--
--
--
--
--
8.84K
-92.73%
--
--
--
--
-33.06K
--
10.48K
+18.64%
11.16K
--
-994.83
--
2.16K
+106.53%
15.41K
+47.00%
1.16M
+10320.01%
1.44M
+145224.52%
1.23M
+7859.32%
1.23M
--
Gain (Loss) on Foreign Currency Exchange
0
--
--
--
0
--
--
--
--
--
121.60K
--
--
--
--
--
--
--
8.84K
-92.73%
--
--
--
--
-33.06K
--
10.48K
+18.64%
11.16K
--
-994.83
--
-15.47K
+53.20%
-6.89K
-165.74%
1.16M
+10293.14%
1.09M
+109313.22%
135.54K
+2066.60%
135.54K
--
Net Interest Expense
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0
--
--
--
--
--
0
--
0
--
0
--
0
--
-17.63K
--
-22.30K
--
-3.00K
--
-357.26K
--
-1.09M
-4791.92%
-1.09M
--
Interest Income
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0
--
--
--
--
--
0
--
0
--
0
--
0
--
17.63K
--
22.30K
--
3.00K
--
357.26K
--
1.09M
+4791.92%
1.09M
--
Pretax Income From Continuing Operations
-59.44K
--
-34.08K
--
-360.56K
-506.59%
-1.79M
-5152.01%
-4.66M
--
-6.83M
-1793.19%
-3.80M
--
-7.49M
-318.26%
-9.33M
-100.01%
-10.88M
-59.42%
-1.73M
+54.61%
-3.24M
+56.69%
-4.42M
+52.64%
-5.45M
+49.95%
-1.28M
+26.08%
-1.67M
+48.56%
-1.48M
+66.44%
-2.07M
+61.93%
34.45K
+102.70%
-2.02M
-20.95%
-8.78M
-323.42%
-8.78M
--
Net Income
-59.44K
--
-34.08K
--
-360.56K
-506.59%
-1.79M
-5152.01%
-4.66M
--
-6.83M
-1793.19%
-3.80M
--
-7.49M
-318.26%
-9.33M
-100.01%
-10.88M
-59.42%
-1.73M
+54.61%
-3.24M
+56.69%
-4.42M
+52.64%
-5.45M
+49.95%
-1.28M
+26.08%
-1.67M
+48.56%
-1.48M
+66.44%
-2.07M
+61.93%
34.45K
+102.70%
-2.02M
-20.95%
-8.78M
-323.42%
-8.78M
--
Net Income Attributable to Owners of the Company
-59.44K
--
-34.08K
--
-360.56K
-506.59%
-1.79M
-5152.01%
-4.66M
--
-6.83M
-1793.19%
-3.80M
--
-7.49M
-318.26%
-9.33M
-100.01%
-10.88M
-59.42%
-1.73M
+54.61%
-3.24M
+56.69%
-4.42M
+52.64%
-5.45M
+49.95%
-1.28M
+26.08%
-1.67M
+48.56%
-1.48M
+66.44%
-2.07M
+61.93%
34.45K
+102.70%
-2.02M
-20.95%
-8.78M
-323.42%
-8.78M
--
Net Income Attributable to Common Stockholders
-59.44K
--
-34.08K
--
-360.56K
-506.59%
-1.79M
-5152.01%
-4.66M
--
-6.83M
-1793.19%
-3.80M
--
-7.49M
-318.26%
-9.33M
-100.01%
-10.88M
-59.42%
-1.73M
+54.61%
-3.24M
+56.69%
-4.42M
+52.64%
-5.45M
+49.95%
-1.28M
+26.08%
-1.67M
+48.56%
-1.48M
+66.44%
-2.07M
+61.93%
34.45K
+102.70%
-2.02M
-20.95%
-8.78M
-323.42%
-8.78M
--
Total Comprehensive Income
-59.44K
--
-34.08K
--
-360.56K
-506.59%
-1.79M
-5152.01%
-4.66M
--
-6.83M
-1793.19%
-3.80M
--
-7.49M
-318.26%
-9.33M
-100.01%
-10.88M
-59.42%
-1.73M
+54.61%
-3.24M
+56.69%
-4.42M
+52.64%
-5.45M
+49.95%
-1.28M
+26.08%
-1.67M
+48.56%
-1.48M
+66.44%
-2.07M
+61.93%
34.45K
+102.70%
-2.02M
-20.95%
-8.78M
-323.42%
-8.78M
--
Total Comprehensive Income Attributable to Owners of the Company
-59.44K
--
-34.08K
--
-360.56K
-506.59%
-1.79M
-5152.01%
-4.66M
--
-6.83M
-1793.19%
-3.80M
--
-7.49M
-318.26%
-9.33M
-100.01%
-10.88M
-59.42%
-1.73M
+54.61%
-3.24M
+56.69%
-4.42M
+52.64%
-5.45M
+49.95%
-1.28M
+26.08%
-1.67M
+48.56%
-1.48M
+66.44%
-2.07M
+61.93%
34.45K
+102.70%
-2.02M
-20.95%
-8.78M
-323.42%
-8.78M
--
Basic EPS
-0.03
--
-0.01
--
-0.1
-233.33%
-0.28
-2700.00%
-0.58
--
-3.8
-3700.00%
-0.32
--
-0.63
-125.00%
-3.92
-575.86%
-4.41
-16.05%
-0.48
-50.00%
-0.88
-39.68%
-1.19
+69.64%
-1.46
+66.89%
-0.33
+31.25%
-0.4
+54.55%
-0.35
+70.59%
-0.48
+67.12%
0.01
+103.03%
-0.31
+22.50%
-1.28
-166.67%
-1.28
--
Basic EPS from Continuing Operations
-0.03
--
--
--
-0.1
-233.33%
--
--
--
--
-3.8
-3700.00%
--
--
--
--
--
--
-4.41
-16.05%
--
--
--
--
-1.19
--
-1.46
+66.89%
-0.33
--
-0.4
--
-0.35
+70.59%
-0.48
+67.12%
0.01
+103.03%
-0.31
+22.50%
-1.28
-166.67%
-1.28
--
Diluted EPS
-0.03
--
-0.01
--
-0.1
-233.33%
-0.28
-2700.00%
-0.58
--
-3.8
-3700.00%
-0.32
--
-0.63
-125.00%
-3.92
-575.86%
-4.41
-16.05%
-0.48
-50.00%
-0.88
-39.68%
-1.19
+69.64%
-1.46
+66.89%
-0.33
+31.25%
-0.4
+54.55%
-0.35
+70.59%
-0.48
+67.12%
0.01
+103.03%
-0.31
+22.50%
-1.28
-166.67%
-1.28
--
Diluted EPS from Continuing Operations
-0.03
--
--
--
-0.1
-233.33%
--
--
--
--
-3.8
-3700.00%
--
--
--
--
--
--
-4.41
-16.05%
--
--
--
--
-1.19
--
-1.46
+66.89%
-0.33
--
-0.4
--
-0.35
+70.59%
-0.48
+67.12%
0.01
+103.03%
-0.31
+22.50%
-1.28
-166.67%
-1.28
--